Source: J+D Blog

J+D Blog Introducing Our Cutting-Edge Analogue Tool: Forecasting with Precision and Insight

In pharmaceutical forecasting, accurate data is crucial for strategic decision-making. Introducing our new Analogue Tool, meticulously designed by experts for forecasters. This tool features a comprehensive analogue library, providing up to 2,000 oncology analogues across 20 indications. It offers advanced filtering, patient-level data, and a user-friendly interface, ensuring precise and actionable insights. Whether in early-stage planning, launch readiness, or lifecycle management, our tool enhances forecast accuracy, transparency, and efficiency.The post Introducing Our Cutting-Edge Analogue Tool: Forecasting with Precision and Insight appeared first on J+D Forecasting.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
David James's photo - CEO of J+D

CEO

David James

CEO Approval Rating

90/100

Read more